Rand Capital makes follow-on investment in BroadOak-backed Empire Genomics

Rand Capital Corporation made a follow-on investment of $250,000 as part of a $1.75 million financing round in Empire Genomics, a molecular diagnostics company. Existing investor BroadOak Capital Partners led the funding round.

Source: Press Release